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Abstract 15 
 16 
Complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) belong to 17 
the family of beta2 integrins and are expressed mainly by myeloid cell types in humans. 18 
Previously, we proved that CR3 rather than CR4 plays a key role in phagocytosis. Here 19 
we analysed how CD11b and CD11c participate in cell adhesion to fibrinogen, a 20 
common ligand of CR3 and CR4, employing human monocytes, monocyte-derived 21 
macrophages (MDMs) and monocyte-derived dendritic cells (MDDCs) highly 22 
expressing CD11b as well as CD11c. We determined the exact numbers of CD11b 23 
and CD11c on these cell types by a bead based technique, and found that the ratio of 24 
CD11b/CD11c is 1.2 for MDDCs, 1.7 for MDMs and 7.1 for monocytes, suggesting that 25 
the function of CD11c is preponderant in MDDCs and less pronounced in monocytes. 26 
Applying state-of-the-art biophysical techniques, we proved that cellular adherence to 27 
fibrinogen is dominated by CD11c. Furthermore, we found that blocking CD11b 28 
significantly enhances the attachment of MDDCs and MDMs to fibrinogen, 29 
demonstrating a competition between CD11b and CD11c for this ligand. On the basis 30 
of the cell surface receptor numbers and the measured adhesion strength we set up a 31 
model, which explains the different behavior of the three cell types. 32 
 33 
Introduction 34 
 35 
Monocytes, macrophages and dendritic cells are phagocytes, which are able to 36 
adhere to extracellular matrix components (e.g. fibrinogen) via different integrin 37 
molecules. Integrins are heterodimeric transmembrane glycoproteins consisting of a 38 
non-covalently coupled alpha and beta chain [1]. These molecules mediate several 39 
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functions that are associated with cytoskeleton rearrangements, including cell-to-cell 40 
and cell-ECM contacts, proliferation, phagocytosis and transendothelial migration of 41 
immune cells [1-4]. The most abundant integrins expressed by cells of the monocytic 42 
linage are complement receptors (CR) CR3 (CD11b/CD18) and CR4 (CD11c/CD18), 43 
which are members of the β2 integrin family. The main natural ligand of CR3 and CR4 44 
is iC3b, the inactivated fragment of C3, the central complement component [5], 45 
however, they bind several other molecules in common, like fibrinogen, ICAM-1, factor 46 
X, etc. [6-11].  47 
In humans, CR3 and CR4 are simultaneously expressed in monocytes, 48 
macrophages, dendritic cells, neutrophil granulocytes (PMNs) and NK cells. Since the 49 
main ligand of CR3 and CR4 is identical, the study of the individual function of these 50 
integrins is challenging. In contrast to the human system, murine CD11c/CD18 51 
expression is mainly limited to dendritic cells, therefore CR4 can be used to identify 52 
this cell population.  Furthermore the function as well as signal transduction mediated 53 
by mouse CR3 can be separately studied [12-15]. Results obtained in studies on 54 
mouse CD11b/CD18 however cannot be simply translated to the human system, due 55 
to the previously mentioned differences between the two species.  Our goal is to 56 
dissect and determine the individual functional properties of human CR3 57 
(CD11b/CD18) and CR4 (CD11c/CD18). 58 
Earlier we demonstrated that CR3 plays a key role in the phagocytosis of iC3b-59 
opsonized microbes by human MDDCs, while their maturation and inflammatory 60 
cytokine production is not influenced by iC3b or CD11b specific antibody [16, 17]. We 61 
also examined the role of CD11c/CD18 in the complement mediated phagocytosis of 62 
MDDCs, and found it dispensable in this process, proving that the function of CR3 and 63 
CR4 is not identical. The aim of the present work is to determine the participation of 64 
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CR3 and CR4 in a different function linked to β2 integrins; namely cellular adhesion. 65 
The absolute numbers and the conformational state of CR3 and CR4 expressed by the 66 
cells were assessed and the adherence of normal human monocytes, MDDCs and 67 
MDMs to fibrinogen was investigated. The strength and the kinetics of adherence were 68 
estimated using classical and state-of-the-art biophysical methods. Our results provide 69 
further evidence that human CR3 and CR4 are involved in different cellular functions - 70 
despite their capacity to bind the same ligands. 71 
 72 
Results 73 
 74 
Absolute number and conformation analysis of 75 
CD11b/CD18 and CD11c/CD18 on monocytes, MDMs and 76 
MDDCs 77 
Our aim was to compare the role of CD11b and CD11c in adhesion to fibrinogen 78 
on monocytes, MDMs and MDDCs. To achieve this goal, first we had to assess the 79 
exact number of the receptors expressed by the cells, which has not been determined 80 
in a comprehensive manner so far.  To this end we used Qifikit (Dako), a bead based 81 
flow cytometric technique, which enables the determination of absolute receptor 82 
numbers. Although monocytes, macrophages and dendritic cells are thought to 83 
express CD11b and CD11c in similarly high amounts, precise numbers assessed by 84 
us show significant differences. The number of CD11b molecules on the cell surface 85 
is 247174+/-21281 for MDDCs, 309753+/-62045 for MDMs and 49831+/-7810 for 86 
CD14+ monocytes.  Assessing CD11c expression we detected 203996+/-24623 for 87 
MDDCs, 185357+/-40160 for MDMs and 6972+/-2972 for CD14+ monocytes (Fig 1A). 88 
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We also calculated the CD11b:CD11c ratio on these cell types, and found 1,2 for 89 
MDDCs 1,7 for MDMs and 7,1 for monocytes. Namely, the relative amount of CD11c 90 
to CD11b is the highest in the case of MDDCs intermediate on MDMs and the lowest 91 
on monocytes. This suggests that the functions mediated by CD11c are the most 92 
instrumental in the case of MDDCs.  93 
Since ligand binding by integrins is under conformational regulation, and only 94 
the open form is known to be active [18], next we examined the conformational state 95 
of the receptors. Monocytes, MDDCs and MDMs were stained at 4oC or 37oC with 96 
mAb24 that recognizes the active conformation of CD18, the common β2 chain in CR3 97 
and CR4. We found that all cell types are able to bind mAb24 at 37oC, and to a smaller 98 
extent at 4oC. The difference was statistically not significant in neither of the cases 99 
when analysed by paired t-test. Nevertheless these data clearly show that CR3 and 100 
CR4 are in a conformation capable of ligand binding on the surface of monocytes, 101 
MDDCs and MDMs (Fig 1B). 102 
 103 
Fig 1. Expression and conformation of CD11b and CD11c. (A) The exact amount 104 
of CD11b and CD11c on the surface of monocyte-derived dendritic cells (MDDC), 105 
monocyte-derived macrophages (MDM) and monocytes were determined using Qifikit 106 
(Dako) as described in Materials and methods. Data presented are mean +/-SD of 107 
three independent donors’ results. (B) Cells were stained with monoclonal antibody 108 
mAb24 that is specific for the high affinity conformation of CD18. Relative mean 109 
fluorescence intensity (RMFI) was calculated in each case by comparing the signal of 110 
mAb24 stained cells to isotype matched control antibody stained cells (RMFI=MFI 111 
mAb24/MFI isotype control). At 4oC RMFI values were around 1 (monocytes: 0,60+/-112 
0,22; MDDC: 1,50+/-0,20; MDM: 0,97+/-0,91), meaning that cells do not have active 113 
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β2 integrins on their surface. At 37oC all cell types bound mAb24 (RMFI for monocytes: 114 
2,05+/-0,93; MDDC: 5,07+/-3,15; MDM: 1,87+/-1,42) showing that β2 integrins were in 115 
a conformation capable of ligand binding on their surface. Data presented are mean 116 
+/-SD of three independent donors’ results. 117 
 118 
 119 
Analysis of adhesion to fibrinogen using classical methods 120 
To study the individual role of CD11b/CD18 and CD11c/CD18 in the adhesion 121 
to fibrinogen we blocked either CD11b or CD11c by ligand binding site specific 122 
monoclonal antibodies. Unspecific binding of the antibodies was prevented by adding 123 
FcR blocking reagent to all the samples (including controls), and the number of 124 
adhered cells was determined as percentage of untreated control samples. 125 
Furthermore, treatment with isotype matched control mAbs did not interfere with the 126 
adhesion of each cell type to fibrinogen. As shown in Fig 2A, blocking CD11c 127 
decreased the number of adhering MDDCs and monocytes significantly, and slightly 128 
(not significantly) blocked the adherence of MDMs. Blocking CD11b had no effect on 129 
MDMs and MDDCs, however decreased the number of adhered monocytes slightly 130 
(not significantly). 131 
 Next we aimed to determine how blocking of CD11b/CD18 or CD11c/CD18 132 
receptors affects the properties of adhesion to fibrinogen. To this end we analysed the 133 
contact area of the differently treated MDMs, MDDCs and monocytes by confocal 134 
microscopy. Actin cytoskeleton and nuclei were stained, and 0,42 µm optical sections 135 
of the contact zone were analysed. Fig 2B shows that blocking CD11b on MDMs 136 
results in larger contact areas, while blocking CD11c decreases them compared to 137 
untreated samples. In the case of MDDCs inhibition of CD11b induced a more 138 
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polarized and slightly larger contact surface, while anti-CD11c treated cells showed a 139 
round shape, but similar contact area to control cells. Monocytes are smaller than 140 
MDMs and MDDCs, therefore their contact zone is also smaller, as seen in Fig 2B. 141 
Blocking of CD11b caused an increased contact area also in the case of monocytes, 142 
in contrast to inhibition of CD11c, which had no effect. 143 
To quantify these observations, we established different categories based on 144 
the contact size of the cells. Namely we defined 3 categories for MDMs and MDDCs 145 
and 2 for monocytes (Figs 3A-C), and determined their proportion. By blocking CD11b, 146 
cells with small contact area almost completely disappeared in the case of MDMs and 147 
MDDCs, and their proportion decreased in the sample of monocytes. Simultaneously, 148 
the ratio of spread-out cells increased in the case of all cell types, showing that CD11b 149 
acts against spreading. On the contrary, blocking CD11c elevated the ratio of cells with 150 
small contact area in MDMs and the ratio of medium area cells in MDDCs, but had no 151 
effect on monocytes (Figs 3D-F). 152 
 153 
Fig 2. Number and contact zone structure of cells after blocking CD11b or CD11c 154 
with antibodies. Cells were treated with monoclonal anti-CD11b or anti-CD11c 155 
antibodies on ice for 30 min or left untreated for control. The Fc receptor blocking 156 
reagent was used prior adding the antibodies in all samples. Cells were let to adhere 157 
for 30min at 37oC 5%CO2 on plates coated previously with 10µg/ml fibrinogen and 158 
blocked with PLL-g-PEG. After that cells were fixed with 2% paraformaldehyde for 159 
10min, and washed twice with PBS to remove unbound cells. Nuclei were stained with 160 
Draq5 and actin cytoskeleton with phalloidin-Alexa488 probe. (A) The number of 161 
adhered cells was determined by analysing 12 representative fields after each 162 
treatment using Olympus IX81 microscope at 10x magnification. The number of 163 
adherent cells in control samples was taken 100%, and the effect of different 164 
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treatments was compared to it. Mean +/- SD of three independent donors’ results is 165 
shown. Repeated measures ANOVA with Bonferroni post-test was used to determine 166 
significant differences compared to control *=p<0,05 (B) A 0,42 µm slice of the contact 167 
zone was analysed by 60x magnification. Red fluorescence shows cell nuclei (Draq5), 168 
green shows filamentous actin (phalloidine-Alexa488). 169 
 170 
Fig 3. Contact zone size of cells after blocking CD11b or CD11c with antibodies. 171 
Cells were divided into categories based on the size of their contact zones. MDMs (A) 172 
and MDDCs (B) were categorised into the following three groups: small ≤2000 pixel2, 173 
medium 2000-400 pixel2, large ≥4000 pixel2. For monocytes (c) only 2 categories were 174 
established because of their smaller size (small ≤1000 pixel2, large> 100 pixel2).  200 175 
cells were counted for each cell type and each treatment, and the distribution between 176 
the different contact size categories was determined and is shown for MDDCs (D), 177 
MDMs (E) and monocytes (F). Results of one representative experiment of three 178 
independent ones is shown. 179 
 180 
 181 
 182 
Analysis of adhesion force using computer controlled 183 
micropipette 184 
 To further characterise the role of CD11b/CD18 and CD11c/CD18 in cell 185 
adhesion to fibrinogen, we performed state-of-the-art biophysical measurements on 186 
differently treated cells. Cells were let to adhere on fibrinogen coat, and their adhesion 187 
force was assessed by trying to pick them up with a computer controlled micropipette 188 
using vacuum assisted fluid flow. The pick-up process was repeated several times with 189 
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increasing the vacuum, and cells remaining on the surface were counted after each 190 
cycle. Applied vacuum was converted to force (µN) on the basis of computer 191 
simulations, and experimental data are presented as the ratio of differently treated 192 
adherent cells compared to the untreated control. Using this method we observed that 193 
blocking CD11b increased the force of adhesion of MDDCs significantly and elevated 194 
the force of adhesion in the case of MDMs (not significant, Figs 4A and 4B), however, 195 
it significantly decreased the strength of adhesion in the case of monocytes (Fig 4C). 196 
The significant strengthening and decreasing effect was observed among the cells that 197 
adhered the strongest. This is in good concordance with our previous results showing 198 
that anti-CD11b treatment slightly reduces the number of adhesive monocytes (Fig 199 
2A). This treatment also increased the proportion of cells with medium and large 200 
contact area (Fig 3). Blocking CD11c decreased the adhesion force in each cell type, 201 
underlining the importance of this receptor in the process, however the differences 202 
were not found to be significant. 203 
 204 
Fig 4. Force of cell adhesion after blocking CD11b or CD11c with antibodies. 205 
MDDCs (A), MDMs (B) and monocytes (C) were treated with monoclonal anti-CD11b 206 
or anti-CD11c antibodies on ice for 30 min or left untreated for control. The Fc receptor 207 
blocking agent was used prior adding the antibodies in all samples. Cells were let to 208 
adhere for 30min at 37oC 5%CO2 in Petri dishes coated previously with 10µg/ml 209 
fibrinogen and blocked with PLL-g-PEG. After that cells were gently washed twice with 210 
PBS to remove unbound cells. The number of adhered cells was determined in the 211 
field of the microscope and is shown as 0,00µN. The computer controlled micropipette 212 
made serial pick-up processes in the field by using increasing amount of vacuum. A 213 
microscopic picture was taken after each round and the number of remaining cells was 214 
determined. The ratio of adhered cells was determined at each lifting force value by 215 
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dividing the number of adhered cells in the anti-CD11b or anti-CD11c blocked samples 216 
by the number of cells in corresponding control sample. Data presented are mean +/-217 
SD of three independent donors’ samples. Repeated measures ANOVA with 218 
Bonferroni post-test was used to determine significant differences compared to control 219 
at each force. *=p<0,05, **=p<0,01 220 
 221 
 222 
Analysis of adhesion kinetics using optical waveguide 223 
biosensor 224 
 To perform kinetic studies on adherence to fibrinogen, the EPIC label free 225 
optical biosensor was used. This method enables the real-time monitoring of a 100-226 
200 nm width layer over the adhesive surface by analysing the refractive index 227 
alterations in this volume. Cells can reach this area only by adhesion, thereby non 228 
adhering cells are excluded from the measurement. Signal is detected as the shift of 229 
resonant wavelength (Δλ). The higher this shift, the larger area of the sensor is covered 230 
or the stronger the contact between the cells and their substrate. This means that using 231 
this method we detect a combined signal of the number of the adhered cells and the 232 
size and density of their contact area [19, 20]. The experiment was performed on 233 
MDMs, where the expression of CD11b or CD11c was downregulated using RNA 234 
silencing. For control, cells were transfected with negative control siRNA. To avoid the 235 
undesired contribution of unbound antibodies to the optical sensor antibody blocking 236 
was not used in this method. Fig 5A shows a representative graph, where CD11b 237 
silenced cells show higher, and CD11c silenced cells lower signal, as compared to the 238 
control sample. Since cells were let to adhere for 30 minutes in the case of the other 239 
methods used by us, we determined the mean Δλ value for 3 independent experiments 240 
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at the 30th minute of the kinetic experiment. Data obtained confirm our previous 241 
findings, namely, that blocking CD11c decreased the adhesive capacity of the cells 242 
significantly while blocking CD11b elevated it slightly (not significantly) (Fig 5B). To 243 
validate the results obtained with RNA silenced cells, we assessed their adhesion 244 
profile employing two further methods, too. We analysed the actin clusters of the 245 
contact zone in confocal microscope, and found that CD11b silenced MDMs had 246 
stronger actin clusters than the control cells, and significantly more than the CD11c 247 
silenced cells had. The opposite was true for the weak actin clusters; CD11c silenced 248 
cells had significantly more of that than the CD11b silenced cells (Fig 5C). The 249 
computer controlled micropipette confirmed these results (Fig 5D) showing that RNA 250 
silencing caused similar changes in the cells’ adhesive capacity as receptor blocking 251 
with antibodies. 252 
 253 
Fig 5. Adhesion of RNA silenced macrophages. MDMs were differentiated under 254 
conditions where CD11b or CD11c expression was downregulated by receptor specific 255 
siRNA. Control cells were treated with negative control siRNA. (A) Kinetic curves of 256 
adhering cells was recorded by EPIC BT measurement. Change in refractive index and 257 
thereby detected wavelength (Δλ) is plotted against time in the case of CD11b (dashed 258 
line), CD11c (dotted line) or negative control (black line) silenced MDMs of the same 259 
donor. The shaded area around each line shows the deviation between the parallel 260 
samples. One representative measurement out of three independent is shown. (B) 261 
Average+/-SD Δλ of three independent measurements was determined at the 30th 262 
minute of analysis. Paired t-test was used to compare the effect of CD11b or CD11c 263 
silencing compared to control siRNA treated samples. CD11c silencing was found to 264 
decrease Δλ significantly (p<0,5)  (C) Cells were let to adhere for 30min at 37oC 5%CO2 265 
on plates coated previously with 10µg/ml fibrinogen and blocked with PLL-g-PEG. 266 
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Filamentous actin was stained with phalloidine-Alexa488 and contact zones were 267 
scanned for 200 cells with Olympus IX81 confocal microscope using 60x objective. 268 
Pictures were analysed for the amount of strong and weak actin clusters with ImageJ. 269 
CD11b and CD11c silenced cells were compared to negative control siRNA treated 270 
cells. MDMs with reduced CD11b had significantly more strong clusters and 271 
significantly less weak clusters compared to CD11c silenced cells. Results shown are 272 
mean +/- SD of three independent experiments, repeated measures ANOVA with 273 
Bonferroni post-test was used, *=p<0,05, **=p<0,01. (D) The number of cells adhering 274 
with a given force was determined by the computer controlled micropipette. MDMs with 275 
silenced CD11b had significantly more cells that adhered with strong force compared 276 
to negative control siRNA treated cells. Differences in the case of CD11c silencing 277 
were not significant. Results shown are mean +/- SD of three independent 278 
experiments, repeated measures ANOVA with Bonferroni post-test was used, 279 
**=p<0,01, ***=p<0,001 280 
 281 
 282 
Discussion 283 
 284 
The family of β2 integrins consists of four members: CD11a/CD18 (LFA-1), 285 
CD11b/CD18 (CR3, Mac-1), CD11c/CD18 (CR4, p150/95) and CD11d/CD18. The role 286 
of LFA-1 in lymphocyte trafficking is well characterised, however, the role of 287 
CD11d/CD18 is still unexplored [21]. Although the function of CD11b/CD18 and 288 
CD11c/CD18 is being investigated for long, dissecting their individual role is technically 289 
challenging for many reasons. It is important to emphasize that their expression pattern 290 
is fundamentally different in mice and men. In the mouse CD11b is expressed on all 291 
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myeloid cells, while CD11c is present mainly on dendritic cells. Due to this differential 292 
expression in mice signal transduction via CD11b/CD18 is well characterized [13, 15] 293 
but is not fully known in the case of the other β2 integrins. Activation of β2 integrins 294 
was shown to be linked to Src family kinases Hck and Fgr further leading to Syk 295 
signalling via DAP12, the adaptor molecule in murine neutrophils and macrophages 296 
[13, 14, 22].  297 
 In contrast to mice, in humans CD11b and CD11c are simultaneously 298 
expressed on a wide variety of myeloid cells, as well as on certain populations of 299 
lymphoid cells [8, 23, 24]. What makes their analysis even more challenging is their 300 
overlapping ligand specificity. They have several common ligands, including 301 
inactivated C3b fragment (iC3b), fibrinogen and ICAM-1 [6, 10, 11, 25-27], and due to 302 
this it has been postulated that the function of CR3 and CR4 is similar. Namely, they 303 
mediate adhesion to ICAM-1 and fibrinogen and phagocytosis of iC3b opsonised 304 
particles. However, from an evolutionary point of view it does not seem economical to 305 
express two different receptors with identical functions by the same cell. Moreover, the 306 
intracellular domain of CD11b and CD11c in humans differ in length and amino acid 307 
sequence [1, 24, 28], which suggests functional differences between CR3 and CR4. 308 
Our goal was to dissect the functions of CR3 and CR4 in the human system. 309 
Previously we analysed the iC3b mediated phagocytosis of human MDDCs and 310 
concluded that CR4 does not take part in this process [17]. In the present work we 311 
focused our attention on adhesion, the other main function of β2 integrins. The 312 
importance of this integrin mediated function is clearly seen in the pathologic condition 313 
of lymphocyte adhesion deficiency (LAD) syndromes type I, II and III, where defective 314 
adhesive properties of leukocytes lead to recurrent and severe life threatening 315 
infections [3]. To explore the differences between CR3 and CR4 we tested the 316 
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adhesive capacity of human monocytes, MDDCs and MDMs on fibrinogen coated 317 
surface.  318 
Fibrinogen has medium affinity to both CD11b and CD11c, suggesting that this 319 
ligand binds to both receptors, which might compete for the ligand. Examination of the 320 
affinity of fibrinogen binding to a 200 amino acid long recombinant CD11b I domain 321 
revealed in one study a Kd of 2,2x10-7M [11], while others have shown an affinity of 322 
Kd=2x10-4M [29].  In the case of CD11c a Kd=5x10-5M was determined for fibrinogen 323 
[29]. It has also been shown that both CD11b and CD11c can bind the large variant of 324 
fibrinogen (fibrinogen-420), further supporting the idea of simultaneous and 325 
competitive binding [7].   326 
 Here, using different techniques we show, that CD11c/CD18 is the main 327 
receptor that mediates strong adhesion of MDMs and MDDCs to fibrinogen. We have 328 
to keep in mind that the various methods used in the study reveal different aspects of 329 
adhesion. Namely, the static end-point adhesion assay measures the amount of cells 330 
capable of adhering to the substrate, while the computer controlled micropipette assay 331 
measures the strength of adhesion of the same cells. By blocking CD11c the strength 332 
of adherence was strongly reduced in the case of all analysed cell types, and the 333 
contact area of MDMs was significantly smaller than that of the other cell types. 334 
Surprisingly, blocking CD11b results in an even stronger adhesion of MDMs and 335 
MDDCs, along with a larger and more polarized contact area. These data suggest that 336 
although CD11b/CD18 is able to bind fibrinogen [10, 25], it can have a negative role in 337 
the adhesion of these two cell types. Nevertheless, in the case of monocytes, blocking 338 
both CD11b and CD11c decreased the force of adhesion. To resolve this paradoxon, 339 
we propose the following hypothesis. Adhesion to fibrinogen is dependent on the total 340 
number of CD11b/CD18 and CD11c/CD18 receptors on the cell surface. In a 341 
15 
 
preliminary experiment we found that the number of fibrinogen ligands on the adhesive 342 
surface is comparable with the total amount of receptors found on monocytes. Since 343 
there is enough ligand available for both receptors, this suggests that in the case of 344 
monocytes, there is no competition between the two receptors for ligand binding, rather 345 
both take part in the adhesion process equally. This idea needs further support by 346 
analysing the CD11b/CD11c mediated adhesion of neutrophils, which express the two 347 
receptors in similar amounts to monocytes. In previous adhesion studies performed on 348 
monocytes and neutrophil granulocytes, both CD11b and CD11c mediated adhesion 349 
and spreading, suggesting that the adhesion properties of these cell types are similar 350 
[30-34]. However, MDMs and MDDCs bear far more receptors than the number of 351 
accessible ligands on the surfaces we constructed, thereby CD11b/CD18 and 352 
CD11c/CD18 compete for ligand binding. Our hypothesis raises further questions 353 
about cell adhesion under inflammatory conditions, when the number of ligands is 354 
increased and the amount of receptors also changes [8, 35].  Furthermore the 355 
expression and role of CD11d/CD18 in binding to physiological fibrinogen would be 356 
worth to study in more detail, since this receptor was also suggested to be able to bind 357 
this ligand [36].  358 
Adhesion properties of myeloid cells, especially monocytes and neutrophils, are 359 
of particular importance in several pathologic conditions. They play an important role 360 
in atherosclerosis, where fibrinogen accumulation is detected under the endothelial 361 
layer, furthermore, monocytes were shown to upregulate CD11b and CD11c 362 
expression under hypertriglyceridemic conditions [37, 38] or in rheumatoid arthritis, 363 
where elevated CD11b levels and enhanced adhesive properties of monocytes were 364 
already shown [39]. Another pathophysiologic aspect might be related to the 365 
rs1143679 (R77H) SNP of the ITGAM (CD11b) gene, that is associated with systemic 366 
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lupus erythematosus [40]. In this case impaired function of monocytes and MDMs, 367 
MDDCs and neutrophil granulocytes of the risk allele carrying patients was shown [41-368 
44]. Our results shown here suggest that the impaired function may be not only the 369 
consequence of compromised CD11b, but could also be caused by the enhanced 370 
functionality and ligand binding capacity of CD11c in the absence of its competitor. 371 
This might affect mainly the functions of macrophages and dendritic cells, and thereby 372 
the adaptive immune response generated by these antigen-presenting cells. The 373 
importance of cell adhesion under pathologic conditions is further highlighted by the 374 
role of β2 integrins in forming physiological podosomes and invadosomes of cancer 375 
cells [45-48]. These structures mediate the invasion and migration of transformed cells 376 
by ECM degradation. Moreover it was shown that proteolytic digestion of fibrinogen, a 377 
component of the ECM, enhances its recognition by CD11c on human neutrophils [29].  378 
Our recent findings highlighting the difference between the function of human 379 
CD11b/CD18 and CD11c/CD18 facilitates an even more detailed analysis of the 380 
individual role of these molecules. The state-of-the-art biophysical methods we used 381 
provide a yet unexploited potential for the analysis of cell functions, like adhesion under 382 
steady state and pathological conditions [19, 20, 49]. The possibility of cell type specific 383 
competition or cooperation between CR3 and CR4 raises several questions regarding 384 
integrin functions however the role of additional receptors in adhesion to fibrinogen 385 
cannot be excluded. Still, our results contribute to a better understanding of the distinct 386 
functions of CR3 and CR4. Whether the number and the type of the ligands they bind, 387 
or the ratio of the receptors expressed will determine the outcome of the interaction, 388 
needs further investigation.  389 
 390 
Materials and Methods 391 
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 392 
Ethics statement 393 
The study was conducted in accordance with the ethical guidelines of Declaration of 394 
Helsinki and approved by the Hungarian Medical Research Council Scientific and 395 
Research Committee (ETT TUKEB, permission number: 55627/2012/EKU). Blood 396 
samples were purchased from the Hungarian Blood Transfusion Service, where an 397 
informed written consent was obtained from all the donors. 398 
Isolation of monocytes 399 
 Monocytes were isolated from buffy coat obtained from healthy donors and 400 
provided by the Hungarian National Blood Transfusion Service. Peripheral blood 401 
mononuclear cells (PBMC) were separated by Ficoll-Paque PLUS (GE Healthcare Life 402 
Sciences) density gradient centrifugation and monocytes were isolated negatively by 403 
using the Miltenyi Monocyte Isolation Kit II. 404 
 405 
Generation of monocyte-derived macrophages (MDMs) and 406 
monocyte-derived dendritic cells (MDDCs) 407 
To generate MDMs and MDDCs monocytes were isolated by Miltenyi CD14 408 
MicroBeads to obtain high yield of cells. The isolated cells were cultivated for 5 days 409 
in RPMI-1640 medium (Sigma-Aldrich) supplemented with 10%FCS (Sigma-Aldrich), 410 
and Gentamicin antibiotics (Sigma-Aldrich). To generate MDMs 100 ng/mL rHu GM-411 
CSF (R&D systems) was added to the isolated monocytes. To generate MDDCs 100 412 
ng/mL rHu GM-CSF (R&D systems) and 15 ng/mL rHu IL-4 (R&D systems) were added 413 
to the monocytes [50-52]. Cytokines were supplied on day 3 of differentiation. To 414 
identify differentiated MDMs and MDDCs at day5 of cultivation we checked the cultures 415 
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by flowcytomery: dendritic cells are CD14-, while macrophages are CD14+. 416 
Furthermore, we analyse the cultures by inverted microscope. Dendritic cells are non-417 
adherent at day5 with several dendrites in contrast to macrophages, which are 418 
attached to the culture plate, and have a rounded shape without dendrites. The 419 
populations were found to be 95%< homogenous in size, granulation and 420 
differentiation stage as determined by flow cytometric measurements. 421 
 422 
Determination of absolute receptor numbers on cell 423 
surface 424 
 Absolute numbers of CD11b and CD11c was determined on the surface of 425 
monocytes, MDMs and MDDCs by using Qifikit (Dako) according to the manufacturers’ 426 
instructions. Briefly, cells were incubated with unlabelled mouse monoclonal antibodies 427 
specific for either CD11b or CD11c at saturating concentrations. After that cells were 428 
labelled with goat-anti-mouse FITC secondary antibody. A calibration curve was 429 
determined using beads that carry defined amount of mouse IgG to specify the 430 
correlation between fluorescence intensity and number of antibodies bound. This 431 
equation was used to determine the number of bound anti-CD11b or anti-CD11c 432 
antibodies on the cells’ surface. The same unlabelled mouse monoclonal antibodies 433 
were used as for receptor blocking in saturating concentration that was previously 434 
titrated by flow cytometry. 435 
 436 
Analysis of integrin conformational state 437 
 Integrins’ ligand binding properties highly depend on their conformation. To this 438 
end we incubated the cells with monoclonal antibody mAb24 (Hycult Biotech) that 439 
recognizes the high affinity conformation of CD18. After that, cell-bound mAb24 was 440 
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labelled with goat-anti-mouse IgG Alexa488 (Molecular Probes, Invitrogen). Samples 441 
were analysed on BD FACS Calibur flowcytometer using CellQuest software for data 442 
acquisition and FCS Express 3.0 software for data analysis. We compared the cells 443 
mAb24 staining in the media used for adhesion at 4oC and 37oC compared to isotype 444 
control staining in each case.  445 
 446 
Blocking of CD11b/CD18 and CD11c/CD18 by antibodies 447 
 The role of CD11b/CD18 and CD11c/CD18 in the adhesion to fibrinogen was 448 
analysed by comparing the adhesive properties of monocytes, MDMs and MDDCs 449 
treated with either anti-CD11b antibody (monoclonal mIgG1 clone TMG6-5, provided 450 
by István Andó at BRC Szeged, Hungary) or anti-CD11c antibody (monoclonal mIgG1 451 
clone 3.9, Biolegend). Both antibodies are specific for the ligand binding domain of the 452 
integrins and were used in sterile, azide-free form at saturating concentration 453 
previously titrated by flow cytometry. Cells were incubated with the receptor-specific 454 
antibodies for 30min at 4oC and used in adhesion studies without washing. Since 455 
unoccupied integrins are known to recycle to the cell surface, and would decrease the 456 
efficiency of blocking, unbound antibodies were not washed away. Cells were 457 
incubated in the presence of FcR blocking reagent (Miltenyi Biotech), and the effect of 458 
receptor specific antibodies was compared to untreated samples that were incubated 459 
only with FcR blocking reagent.  460 
 461 
RNA silencing in macrophages 462 
 RNA silencing was performed according to the method of Prechtel [53]. We used 463 
commercially available predesigned Qiagen (Germany) AllStar Negative control siRNA 464 
and Qiagen Genome Wide predesigned siRNA for CD11c (Hs_ITGAX_6) and CD11b 465 
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(Hs_ITGAM_5). Cells were transfected on day3 and day5 of differentiation with 20µg 466 
siRNA to generate CD11c silenced, CD11b silenced or negative control silenced 467 
MDMs at day6. The expression of CD11c and CD11b was analysed on day6 by 468 
cytofluorimetry and subsequent experiments were carried out on the same day. 469 
 470 
Analysis of adhesion by confocal microscopy 471 
 Wells were coated by 10μg/ml fibrinogen in phosphate buffered saline solution 472 
(PBS) for 1 hour at 37oC. After that wells were washed 2 times with PBS and free 473 
surfaces were blocked with synthetic copolymer poly(L-lysine)-graft-poly(ethylene 474 
glycol) (PLL-g-PEG, SuSoS AG) for 30min at RT. After washing 2 times with PBS, 475 
5x104 cells in RPMI1640-10%FCS were immediately transferred to the wells and let to 476 
adhere for 30min at 37oC in a CO2 incubator. After the incubation samples were fixed 477 
by 2% paraformaldehyde (Sigma-Aldrich) for 10min and unbound cells were removed 478 
by extensive washing 2 times with PBS.  479 
 The number of adhered cells was determined by staining the nuclei with Draq5 480 
(BioLegend) diluted 2000x in PBS and incubated for 15min at RT. Samples were 481 
analysed by Olympus IX81 confocal microscope (10x objective) and FluoView500 482 
software. 4 representative fields were scanned in each well of triplicate sample, thereby 483 
the number of adhered cells was determined in 12 parallel fields for each treatment by 484 
ImageJ software. 485 
 To analyse the contact zone of the cells actin cytoskeleton was stained with 486 
phalloidin-Alexa488 (Molecular Probes, Invitrogen). The probe was 100x diluted in 487 
PBS-0,1% Triton-X (Sigma-Aldrich) and cells were stained for 5min at 37oC and after 488 
that washed 3 times with PBS. Samples were analysed by Olympus IX81 confocal 489 
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microscope (60x objective) and FluoView500 software. Pictures were further analysed 490 
by ImageJ software. 491 
 492 
Analysis of adhesion with the computer-controlled 493 
micropipette  494 
Single cell adhesion force was analysed with an imaging-based automated 495 
micropipette (CellSorter) as described previously [49, 54]. Briefly, Petri dishes were 496 
coated by 10μg/ml fibrinogen in phosphate buffered saline solution (PBS) for 1 hour at 497 
37oC. Dishes were washed 2 times with PBS and the surface was blocked with the 498 
synthetic copolymer poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG, SuSoS 499 
AG) in order to inhibit non-specific cell adhesion for 30 min at RT. After washing the 500 
Petri dish again with PBS, 7,5x104 cells in RMPI-10% FCS were placed onto the coated 501 
surface. Cells were incubated for 30 minutes at 37°C in 5% CO2 atmosphere.  Cultures 502 
were washed 3-4 times with Hanks’ Balanced Salt solution with sodium bicarbonate 503 
without phenol red buffer (HBSS, Sigma) to remove floating cells. Region of interest 504 
(ROI) of the Petri dish was scanned by a motorized microscope (Zeiss Axio Observer 505 
A1) equipped with a digital camera (Qimaging Retiga 1300 cooled CCD). Cells were 506 
automatically recognized by the CellSorter software. To minimize the duration of the 507 
measurement, the shortest path of the micropipette was calculated by software [55]. 508 
Individual cells were visited and probed by the glass micropipette. Micropipette with an 509 
aperture of 70 µm approached the surface to a distance of 10 µm. Vacuum was 510 
generated in a standard syringe connected to the micropipette via a high speed 511 
normally closed fluid valve. To probe cell adhesion the valve was opened for 20 ms 512 
generating a precisely controlled fluid flow and corresponding hydrodynamic lifting 513 
force acting only on the targeting cell. The hydrodynamic lifting force was calculated 514 
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by running computer simulation solving the Navier-Stokes equation in a geometry 515 
corresponding to the experimental setup [49]. After each cycle of the adhesion force 516 
measurement the ROI of the Petri dish was scanned again, and the vacuum was 517 
increased to the next level. The micropipette visited again each location determined 518 
after the initial scan. Suction force was increased as long as most of the cells were 519 
removed. We counted the number of cells in the images before and after each cycle of 520 
the adhesion force measurement and calculated the ratio of still adhering cells of the 521 
population placed onto the surface at the beginning of the experiment. 522 
  523 
Analysis of adhesion by EPIC BT biosensor measurement 524 
Kinetic of the adhesion was measured on the Corning EPIC biosensor as described 525 
previously in details [20]. Briefly, each well of a standard microtiter plate contains an 526 
optical grating at its bottom which permits the illuminating light to be incoupled in the 527 
waveguide. Light beams in the waveguide interfere with each other; destructive 528 
interference precludes wave guiding, while constructive interference leads to 529 
resonance and to the excitation of a guided light mode. The latter can be achieved only 530 
at a discrete illuminating wavelength, called resonant wavelength (λ). The guided light 531 
mode generates an exponentially decaying evanescent field in a 100-200 nm thick 532 
layer over the sensor, which probes the local refractive index (RI) at this interface. Any 533 
process accompanied by RI-variations in this layer (bulk RI change, molecular 534 
adsorption, cell spreading, or dynamic redistribution in the cells) untunes the 535 
resonance by altering the phase-shift of the propagating light when it is reflected from 536 
the interface (leading to destructive interference at the original resonance wavelength). 537 
The primary output of the EPIC sensor is then the shift of the resonant wavelength, Δλ. 538 
Wells were coated by 10μg/ml fibrinogen in phosphate buffered saline for 1 hour at 539 
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37oC. After that wells were washed 3 times with PBS and free surfaces were blocked 540 
with synthetic copolymer poly(L-lysine)-graft-poly(ethylene glycol) (PLL-g-PEG, 541 
SuSoS AG) for 30min at RT. After washing 3 times with PBS, 2x104 cells in RPMI-542 
10%FCS were immediately transferred to the wells and the registration of the Δλ was 543 
continuously monitored throughout the experiment (120min). 544 
 545 
Statistical analysis 546 
Two-way ANOVA with Bonferroni post-test or paired t-test was used to determine 547 
significant differences between the differently treated groups, p<0,05 was considered 548 
significant. In each case a minimum of 3 independent donor’s data were analysed549 
  550 
24 
 
References 551 
 552 
1. Tan SM. The leucocyte beta2 (CD18) integrins: the structure, functional regulation and 553 
signalling properties. Biosci Rep. 2012;32(3):241-69. Epub 2012/03/31. 554 
2. Harris ES, McIntyre TM, Prescott SM, Zimmerman GA. The leukocyte integrins. J Biol 555 
Chem. 2000;275(31):23409-12. Epub 2000/05/10. 556 
3. Schmidt S, Moser M, Sperandio M. The molecular basis of leukocyte recruitment and 557 
its deficiencies. Mol Immunol. 2013;55(1):49-58. Epub 2012/12/21. 558 
4. Schwartz MA, Assoian RK. Integrins and cell proliferation: regulation of cyclin-559 
dependent kinases via cytoplasmic signaling pathways. J Cell Sci. 2001;114(Pt 14):2553-60. 560 
Epub 2001/10/31. 561 
5. Rosen H, Law SK. The leukocyte cell surface receptor(s) for the iC3b product of 562 
complement. Current topics in microbiology and immunology. 1990;153:99-122. Epub 563 
1990/01/01. 564 
6. Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. The I domain is a 565 
major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct 566 
adhesion ligands. The Journal of cell biology. 1993;120(4):1031-43. Epub 1993/02/01. 567 
7. Lishko VK, Yakubenko VP, Hertzberg KM, Grieninger G, Ugarova TP. The alternatively 568 
spliced alpha(E)C domain of human fibrinogen-420 is a novel ligand for leukocyte integrins 569 
alpha(M)beta(2) and alpha(X)beta(2). Blood. 2001;98(8):2448-55. Epub 2001/10/06. 570 
8. Mazzone A, Ricevuti G. Leukocyte CD11/CD18 integrins: biological and clinical 571 
relevance. Haematologica. 1995;80(2):161-75. Epub 1995/03/01. 572 
9. Van Strijp JA, Russell DG, Tuomanen E, Brown EJ, Wright SD. Ligand specificity of 573 
purified complement receptor type three (CD11b/CD18, alpha m beta 2, Mac-1). Indirect 574 
effects of an Arg-Gly-Asp (RGD) sequence. J Immunol. 1993;151(6):3324-36. Epub 575 
1993/09/15. 576 
10. Yakubenko VP, Lishko VK, Lam SC, Ugarova TP. A molecular basis for integrin 577 
alphaMbeta 2 ligand binding promiscuity. J Biol Chem. 2002;277(50):48635-42. Epub 578 
2002/10/16. 579 
11. Zhou L, Lee DH, Plescia J, Lau CY, Altieri DC. Differential ligand binding specificities of 580 
recombinant CD11b/CD18 integrin I-domain. J Biol Chem. 1994;269(25):17075-9. Epub 581 
1994/06/24. 582 
12. Giagulli C, Ottoboni L, Caveggion E, Rossi B, Lowell C, Constantin G, et al. The Src family 583 
kinases Hck and Fgr are dispensable for inside-out, chemoattractant-induced signaling 584 
regulating beta 2 integrin affinity and valency in neutrophils, but are required for beta 2 585 
integrin-mediated outside-in signaling involved in sustained adhesion. J Immunol. 586 
2006;177(1):604-11. Epub 2006/06/21. 587 
13. Jakus Z, Simon E, Frommhold D, Sperandio M, Mocsai A. Critical role of phospholipase 588 
Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase 589 
of autoimmune arthritis. J Exp Med. 2009;206(3):577-93. Epub 2009/03/11. 590 
14. Mocsai A, Abram CL, Jakus Z, Hu Y, Lanier LL, Lowell CA. Integrin signaling in neutrophils 591 
and macrophages uses adaptors containing immunoreceptor tyrosine-based activation 592 
motifs. Nat Immunol. 2006;7(12):1326-33. Epub 2006/11/07. 593 
15. Mocsai A, Zhou M, Meng F, Tybulewicz VL, Lowell CA. Syk is required for integrin 594 
signaling in neutrophils. Immunity. 2002;16(4):547-58. Epub 2002/04/24. 595 
25 
 
16. Bajtay Z, Speth C, Erdei A, Dierich MP. Cutting edge: productive HIV-1 infection of 596 
dendritic cells via complement receptor type 3 (CR3, CD11b/CD18). J Immunol. 597 
2004;173(8):4775-8. Epub 2004/10/08. 598 
17. Sandor N, Kristof K, Parej K, Pap D, Erdei A, Bajtay Z. CR3 is the dominant phagocytotic 599 
complement receptor on human dendritic cells. Immunobiology. 2013;218(4):652-63. Epub 600 
2012/08/22. 601 
18. Evans R, Patzak I, Svensson L, De Filippo K, Jones K, McDowall A, et al. Integrins in 602 
immunity. J Cell Sci. 2009;122(Pt 2):215-25. Epub 2009/01/02. 603 
19. Orgovan N, Peter B, Bosze S, Ramsden JJ, Szabo B, Horvath R. Dependence of cancer 604 
cell adhesion kinetics on integrin ligand surface density measured by a high-throughput label-605 
free resonant waveguide grating biosensor. Scientific reports. 2014;4:4034. Epub 2014/02/08. 606 
20. Orgovan N, Salanki R, Sandor N, Bajtay Z, Erdei A, Szabo B, et al. In-situ and label-free 607 
optical monitoring of the adhesion and spreading of primary monocytes isolated from human 608 
blood: dependence on serum concentration levels. Biosensors & bioelectronics. 2014;54:339-609 
44. Epub 2013/12/03. 610 
21. Yakubenko VP, Belevych N, Mishchuk D, Schurin A, Lam SC, Ugarova TP. The role of 611 
integrin alpha D beta2 (CD11d/CD18) in monocyte/macrophage migration. Experimental cell 612 
research. 2008;314(14):2569-78. Epub 2008/07/16. 613 
22. Jakus Z, Fodor S, Abram CL, Lowell CA, Mocsai A. Immunoreceptor-like signaling by 614 
beta 2 and beta 3 integrins. Trends in cell biology. 2007;17(10):493-501. Epub 2007/10/05. 615 
23. Miller LJ, Schwarting R, Springer TA. Regulated expression of the Mac-1, LFA-1, p150,95 616 
glycoprotein family during leukocyte differentiation. J Immunol. 1986;137(9):2891-900. Epub 617 
1986/11/01. 618 
24. Miller LJ, Wiebe M, Springer TA. Purification and alpha subunit N-terminal sequences 619 
of human Mac-1 and p150,95 leukocyte adhesion proteins. J Immunol. 1987;138(8):2381-3. 620 
Epub 1987/04/15. 621 
25. Lishko VK, Kudryk B, Yakubenko VP, Yee VC, Ugarova TP. Regulated unmasking of the 622 
cryptic binding site for integrin alpha M beta 2 in the gamma C-domain of fibrinogen. 623 
Biochemistry. 2002;41(43):12942-51. Epub 2002/10/23. 624 
26. Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein SC, Loike JD. Complement receptor 625 
type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. 626 
Proc Natl Acad Sci U S A. 1988;85(20):7734-8. Epub 1988/10/01. 627 
27. Zhang L, Plow EF. A discrete site modulates activation of I domains. Application to 628 
integrin alphaMbeta2. J Biol Chem. 1996;271(47):29953-7. Epub 1996/11/22. 629 
28. Arnaout MA, Gupta SK, Pierce MW, Tenen DG. Amino acid sequence of the alpha 630 
subunit of human leukocyte adhesion receptor Mo1 (complement receptor type 3). The 631 
Journal of cell biology. 1988;106(6):2153-8. Epub 1988/06/01. 632 
29. Vorup-Jensen T, Carman CV, Shimaoka M, Schuck P, Svitel J, Springer TA. Exposure of 633 
acidic residues as a danger signal for recognition of fibrinogen and other macromolecules by 634 
integrin alphaXbeta2. Proc Natl Acad Sci U S A. 2005;102(5):1614-9. Epub 2005/01/25. 635 
30. Berton G, Laudanna C, Sorio C, Rossi F. Generation of signals activating neutrophil 636 
functions by leukocyte integrins: LFA-1 and gp150/95, but not CR3, are able to stimulate the 637 
respiratory burst of human neutrophils. The Journal of cell biology. 1992;116(4):1007-17. 638 
Epub 1992/02/01. 639 
31. Georgakopoulos T, Moss ST, Kanagasundaram V. Integrin CD11c contributes to 640 
monocyte adhesion with CD11b in a differential manner and requires Src family kinase activity. 641 
Mol Immunol. 2008;45(13):3671-81. Epub 2008/06/11. 642 
26 
 
32. Keizer GD, Te Velde AA, Schwarting R, Figdor CG, De Vries JE. Role of p150,95 in 643 
adhesion, migration, chemotaxis and phagocytosis of human monocytes. Eur J Immunol. 644 
1987;17(9):1317-22. Epub 1987/09/01. 645 
33. Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, et al. CD11c/CD18 on 646 
neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc 647 
Natl Acad Sci U S A. 1991;88(3):1044-8. Epub 1991/02/01. 648 
34. Pillay J, Kamp VM, Pennings M, Oudijk EJ, Leenen LP, Ulfman LH, et al. Acute-phase 649 
concentrations of soluble fibrinogen inhibit neutrophil adhesion under flow conditions in vitro 650 
through interactions with ICAM-1 and MAC-1 (CD11b/CD18). Journal of thrombosis and 651 
haemostasis : JTH. 2013;11(6):1172-82. Epub 2013/04/16. 652 
35. Montecucco F, Steffens S, Burger F, Da Costa A, Bianchi G, Bertolotto M, et al. Tumor 653 
necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and 654 
migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined 655 
signalling pathways. Cell Signal. 2008;20(3):557-68. Epub 2008/01/01. 656 
36. Yakubenko VP, Yadav SP, Ugarova TP. Integrin alphaDbeta2, an adhesion receptor up-657 
regulated on macrophage foam cells, exhibits multiligand-binding properties. Blood. 658 
2006;107(4):1643-50. Epub 2005/10/22. 659 
37. Gower RM, Wu H, Foster GA, Devaraj S, Jialal I, Ballantyne CM, et al. CD11c/CD18 660 
expression is upregulated on blood monocytes during hypertriglyceridemia and enhances 661 
adhesion to vascular cell adhesion molecule-1. Arterioscler Thromb Vasc Biol. 2011;31(1):160-662 
6. Epub 2010/10/30. 663 
38. Hristov M, Weber C. Differential role of monocyte subsets in atherosclerosis. 664 
Thrombosis and haemostasis. 2011;106(5):757-62. Epub 2011/09/09. 665 
39. Liote F, Boval-Boizard B, Weill D, Kuntz D, Wautier JL. Blood monocyte activation in 666 
rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine 667 
release. Clin Exp Immunol. 1996;106(1):13-9. Epub 1996/10/01. 668 
40. Han S, Kim-Howard X, Deshmukh H, Kamatani Y, Viswanathan P, Guthridge JM, et al. 669 
Evaluation of imputation-based association in and around the integrin-alpha-M (ITGAM) gene 670 
and replication of robust association between a non-synonymous functional variant within 671 
ITGAM and systemic lupus erythematosus (SLE). Human molecular genetics. 2009;18(6):1171-672 
80. Epub 2009/01/09. 673 
41. Fossati-Jimack L, Ling GS, Cortini A, Szajna M, Malik TH, McDonald JU, et al. 674 
Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of 675 
CD11b in human myeloid cells. PloS one. 2013;8(2):e57082. Epub 2013/03/02. 676 
42. MacPherson M, Lek HS, Prescott A, Fagerholm SC. A systemic lupus erythematosus-677 
associated R77H substitution in the CD11b chain of the Mac-1 integrin compromises leukocyte 678 
adhesion and phagocytosis. J Biol Chem. 2011;286(19):17303-10. Epub 2011/04/02. 679 
43. Maiti AK, Kim-Howard X, Motghare P, Pradhan V, Chua KH, Sun C, et al. Combined 680 
protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant 681 
within ITGAM. Human molecular genetics. 2014;23(15):4161-76. Epub 2014/03/13. 682 
44. Rhodes B, Furnrohr BG, Roberts AL, Tzircotis G, Schett G, Spector TD, et al. The 683 
rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 684 
mediated functions in human monocytes. Annals of the rheumatic diseases. 685 
2012;71(12):2028-34. Epub 2012/05/16. 686 
45. Destaing O, Block MR, Planus E, Albiges-Rizo C. Invadosome regulation by adhesion 687 
signaling. Current opinion in cell biology. 2011;23(5):597-606. Epub 2011/05/10. 688 
27 
 
46. Gawden-Bone C, West MA, Morrison VL, Edgar AJ, McMillan SJ, Dill BD, et al. A crucial 689 
role for beta2 integrins in podosome formation, dynamics and Toll-like-receptor-signaled 690 
disassembly in dendritic cells. J Cell Sci. 2014;127(Pt 19):4213-24. Epub 2014/08/03. 691 
47. Gawden-Bone C, Zhou Z, King E, Prescott A, Watts C, Lucocq J. Dendritic cell podosomes 692 
are protrusive and invade the extracellular matrix using metalloproteinase MMP-14. J Cell Sci. 693 
2010;123(Pt 9):1427-37. Epub 2010/04/02. 694 
48. Linder S, Wiesner C. Tools of the trade: podosomes as multipurpose organelles of 695 
monocytic cells. Cellular and molecular life sciences : CMLS. 2015;72(1):121-35. Epub 696 
2014/10/11. 697 
49. Salanki R, Hos C, Orgovan N, Peter B, Sandor N, Bajtay Z, et al. Single cell adhesion assay 698 
using computer controlled micropipette. PloS one. 2014;9(10):e111450. Epub 2014/10/25. 699 
50. Eischen A, Vincent F, Bergerat JP, Louis B, Faradji A, Bohbot A, et al. Long term cultures 700 
of human monocytes in vitro. Impact of GM-CSF on survival and differentiation. J Immunol 701 
Methods. 1991;143(2):209-21. Epub 1991/10/25. 702 
51. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, et al. Generation of mature 703 
dendritic cells from human blood. An improved method with special regard to clinical 704 
applicability. J Immunol Methods. 1996;196(2):137-51. Epub 1996/09/27. 705 
52. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human 706 
dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus 707 
interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 708 
1994;179(4):1109-18. Epub 1994/04/01. 709 
53. Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A. CD83 knockdown in 710 
monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell 711 
stimulation. J Immunol. 2007;178(9):5454-64. Epub 2007/04/20. 712 
54. Ungai-Salanki R, Gerecsei T, Furjes P, Orgovan N, Sandor N, Holczer E, et al. Automated 713 
single cell isolation from suspension with computer vision. Scientific reports. 2016;6:20375. 714 
Epub 2016/02/10. 715 
55. Kornyei Z, Beke S, Mihalffy T, Jelitai M, Kovacs KJ, Szabo Z, et al. Cell sorting in a Petri 716 
dish controlled by computer vision. Scientific reports. 2013;3:1088. Epub 2013/01/22. 717 
 718 
 719 
 720 
